Leo Pharma completes Peplin acquisition
This article was originally published in Scrip
Executive Summary
Denmark's Leo Pharma has completed its acquisition of Peplin for $287.5 million in cash. The deal, which was announced on September 3rd (scripnews.com, September 3rd, 2009), has been approved by Peplin's shareholders.